ArticleJournal for immunotherapy of cancer2025

Targeting TBK1 potentiates oncolytic virotherapy via amplifying ICAM1-mediated NK cell immunity in chemo-resistant colorectal cancer.

Xin Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.